NCCN 2022 Annual Conference

March 31, 2022 to April 2, 2022

The NCCN 2022 Annual Conference is designed to fill real and important medical educational needs of cancer care providers to improve and facilitate quality, effective, efficient and accessible cancer care so patients can live better lives. The Annual Conference focuses on the practical management of patients with cancer, provides updates of NCCN Guidelines, and includes educational sessions on new treatments, therapies, and trends, and their application in patient care. As knowledge about the management of patients with cancer is being developed more rapidly and has become more complex, education on treatment decisions has become increasingly important and valuable. 

Target Audience

This program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician assistants, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

The ultimate goal for NCCN continuing education is to change patient outcomes by improving the competence and performance of clinicians. The goal of the NCCN 2022 Annual Conference is to ensure that members of the interprofessional oncology care team, including physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other relevant health care professionals, have the knowledge and skills necessary to:

  • Apply the current standards of oncology care and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to optimize the management of patients with cancer.
  • Evaluate new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with cancer.
  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with cancer and the delivery of oncology care.

Learning objectives for individual conference sessions are viewable here.

Additional information
Supporters: 

This activity is supported by educational grants from:

  • Abbott Molecular
  • Astellas and Seagen Inc.
  • AstraZeneca
  • BeiGene
  • Coherus BioSciences
  • Daiichi Sankyo
  • Eisai
  • Exact Sciences
  • Genentech, a member of the Roche Group
  • Genmab, US Inc.
  • Gilead Sciences, Inc. and Kite, A Gilead Company
  • GlaxoSmithKline
  • GRAIL, LLC
  • Kadmon Corporation, LLC.
  • Lantheus Medical Imaging Inc.
  • Lilly
  • Menarini-Stemline
  • Novartis
  • NOVOCURE
  • Olympus Corporation of the Americas
  • Pfizer Inc.
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Puma Biotechnology
  • SpringWorks
  • Taiho Oncology, Inc.

This activity is supported by an independent educational grant from:

  • AbbVie
  • Bristol Myers Squibb
  • Incyte
  • Merck & Co., Inc.

This activity is supported by educational funding provided by Amgen.

This activity has been supported by an unrestricted educational grant from GE Healthcare, Pharmaceutical Diagnostics.

This educational activity is supported by an independent medical education grant from Illumina, Inc.

This educational activity is supported by a medical education grant from Karyopharm Therapeutics.

This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company/Global Medical Education Grant Program.

Course summary
Available credit: 
  • 30.00 AAPA Category 1 CME credit
  • 30.00 ACPE contact hours
  • 30.00 AMA PRA Category 1 Credit™
  • 30.00 ANCC contact hours
    • 14.50 ANCC Pharmacology Contact Hours
  • 30.00 CCM clock hours
  • 30.00 Participation
Course opens: 
04/02/2022
Course expires: 
07/01/2022
Event starts: 
03/31/2022 - 9:00am EDT
Event ends: 
04/02/2022 - 3:35pm EDT
Cost:
$0.00

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

PDF icon Click here to download all faculty disclosures.

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 30 contact hours. This program offers 14.5 pharmacotherapeutic contact hours for nurses. Click here to view an agenda where eligible sessions are noted with an asterisk (*).

Pharmacists
NCCN designates this knowledge-based continuing education activity for 30 contact hours (3.0 CEUs) of continuing education credit. UAN: JA4008196-0000-22-018-L01-P

Physician Assistants
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 30 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. The course is approved for 30 CE contact hours. Activity code: C00049987; Approval Number: 220000833

American Board of Internal Medicine Maintenance of Certification


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Pathology Maintenance of Certification


This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Continuing Certification program. Participants may earn up to 30 Lifelong Learning (Part II) credits.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Surgery Continuous Certification (CC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Medical Specialties Maintenance of Certification
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, the NCCN 2022 Annual Conference has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Colon and Rectal Surgery
Pathology
Radiology
Urology

Available Credit

  • 30.00 AAPA Category 1 CME credit
  • 30.00 ACPE contact hours
  • 30.00 AMA PRA Category 1 Credit™
  • 30.00 ANCC contact hours
    • 14.50 ANCC Pharmacology Contact Hours
  • 30.00 CCM clock hours
  • 30.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to start the credit claiming process. You must be logged in with the email address used for registration.

CE/MOC credit should be claimed for the conference as a whole, not session by session. You may claim credit for the conference only one time. When calculating your total credits, you should take into account all of the sessions you viewed either live or via recording. (Please note that you have access to all of the session recordings until eary June.) 

Pharmacists: you must complete all requirements for credit by May 22, 2022.

Tracking Your Session Attendance: Download the PDF icon PDF linked here to help keep track of your session attendance. The enclosed worksheets are for your reference only and should not be returned to NCCN staff. Completion of these worksheets is not required to claim continuing education credit.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing